Zobrazeno 1 - 10
of 20
pro vyhledávání: '"HBsAg lo"'
Autor:
Scott Fung, Belinda Jump, Sang Hoon Ahn, William Guyer, Giovanni Battista Gaeta, Henry Lik-Yuen Chan, Magdy Elkhashab, Gerald Crans, Won Young Tak, Xiaoli Ma, Florin Alexandru Caruntu, Fehmi Tabak, Jörg Petersen, Wan-Long Chuang, Mani Subramanian, R. Mehta, Aric J. Hui, Patrick Marcellin, Alain Chan, Maria Buti, Robert Flisiak, George V. Papatheodoridis
Publikováno v:
Digestive Diseases and Sciences
Background and Aims Hepatitis B surface antigen (HBsAg) loss is the ideal clinical endpoint but is achieved rarely during oral antiviral treatment. A current unmet need in CHB management is achievement of HBsAg loss with a finite course of oral antiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fc17b99d3e8e998fd53f694c174d28
https://doi.org/10.1007/s10620-018-5251-9
https://doi.org/10.1007/s10620-018-5251-9
Publikováno v:
Hepatology International; 2024 Suppl 1, Vol. 18, p1-822, 822p
Autor:
Bello-Corredor, Marité1 marite@ipk.sld.cu, de los Ángeles Rodríguez-Lay, Licel1, Rodríguez-Argueta, Delmira1, Montalvo-Villalba, María Caridad1, Pedroso-Flaquet, Plácido2, Sariego-Frómeta, Susel1, Sánchez-Wong, Meilin1
Publikováno v:
Revista VacciMonitor (Vacunología y Temas Afines). 2016, Vol. 25 Issue 1, p12-18. 7p. 7 Charts.
Autor:
Cabezas, César1,2 ccabezas@ins.gob.pe
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública. 2007, Vol. 24 Issue 4, p378-397. 20p. 2 Diagrams, 4 Charts, 7 Graphs, 2 Maps.
Publikováno v:
Reactions Weekly. 12/3/2005, Issue 1080, p6-23. 18p.
Autor:
Matsubara, Naoko, Kusano, Osamu, Sugamata, Yasuhiro, Itoh, Tetsuo, Mizuii, Masaaki, Tanaka, Junko, Yoshizawa, Hiroshi
Publikováno v:
Transfusion; Mar2009, Vol. 49 Issue 3, p585-595, 11p, 4 Charts, 4 Graphs
Autor:
Porras Ramírez, Alexandra
Publikováno v:
Repositorio UN
Universidad Nacional de Colombia
instacron:Universidad Nacional de Colombia
Universidad Nacional de Colombia
instacron:Universidad Nacional de Colombia
El presente estudio evaluó el impacto de la vacunación contra hepatitis B en el Amazonas, Colombia. Como primera medida se estudió el impacto de la dosis de recién nacidos en una zona endémica de hepatitis B en Colombia. A la fecha no se encuent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a4ebf9b738a3c65baf64118a3aae0af4
https://repositorio.unal.edu.co/handle/unal/59419
https://repositorio.unal.edu.co/handle/unal/59419
Publikováno v:
Journal of Hepatology. 22:119
To the Editor. Most of the new vaccines are thought to be poorly immunogenic in humans (1). For this reason, the use of immunoadjuvants is now considered a positive associated treatment to vaccination. In this pilot study we used AM3 (Inmunofer6na, L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccc9d3db39cce98c79bd287b7f10b16
https://doi.org/10.1016/0168-8278(95)80271-1
https://doi.org/10.1016/0168-8278(95)80271-1
Autor:
Michael L. Bishop
La 8. edición de Química clínica llega por primera vez a los lectores en lengua española. Se trata de un título completo y amigable a la vez que presenta de forma exhaustiva y fácil de comprender los temas que estudiantes y profesionales requer
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C, Brian L. Strom, Gillian J. Buckley
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral